|
Tuesday, September 28, 2010 | 1:00 PM - 5:00 PM | Development of therapies to treat heart failure is hampered by a lack of understanding of underlying mechanisms. This symposium reviews therapeutic approaches, research to identify useful molecular targets, and potential therapeutic approaches. More
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium revisited the 2009 outbreak and examined strategies against future outbreaks. More
Proceedings of the “Ninth Cooley's Anemia Symposium,” held at the New York Academy of Sciences. More
-
Tuesday, September 28, 2010 | 1:00 PM - 5:00 PM
Speakers: Fadi G. Akar (Mount Sinai School of Medicine), Roger J. Hajjar (Mount Sinai School of Medicine), Mariell Jessup (University of Pennsylvania College of Medicine), Walter J. Koch (Thomas Jefferson University), and Evangelia Kranias (University of Cincinnati College of Medicine)
Development of therapies to treat heart failure is hampered by a lack of understanding of underlying mechanisms. This symposium reviews current and potential therapeutic approaches, and research to identify useful molecular targets.
Wednesday, October 6, 2010 | 8:30 AM - 7:00 PM
Chair: Franz Hefti, PhD (Avid Radiopharmaceuticals)
This conference will highlight novel and innovative therapeutic targets for Parkinson’s Disease, biomarkers for early detection and assessment of disease progression, and emerging strategies to alleviate symptoms and/or to slow disease progression.
Friday, November 19, 2010 | 1:00 PM - 5:00 PM
Speakers: Benjamin Haley (Genentech), Philipp Keller (Howard Hughes Medical Institute), Ihor Lemischka (Mount Sinai School of Medicine), Hang Lu (Georgia Institute of Technology) and Stanislav Shvartsman (Princeton University)
Dynamic phenotypes are characterized to help us understand biological function and diagnose illness. This symposium covers high-throughput screening, novel microfluidics devices and modeling to understand biological systems and their environment.
Tuesday, November 30, 2010 | 6:00 PM - 8:00 PM
Speakers: Johanna Daily (Albert Einstein College of Medicine), Jayne Raper (New York University School of Medicine) and Honorine Ward (Tufts University School of Medicine)
Backpacking and city living facilitate the spread of parasites through food and water, via pets or through sexual contact. This symposium provides a research update into parasitic diseases, including sleeping sickness, malaria and Cryptosporidium.
Monday, May 24, 2010 | 1:00 PM - 5:30 PM
Organizers: Doris Bucher (New York Medical College), Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium will revisit the 2009 outbreak and examine strategies against future outbreaks.
Thursday, May 13, 2010 | 8:30 AM - 5:00 PM
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation) and Sonya Dougal (The New York Academy of Sciences)
Please join us for a critical discussion of potential drug therapeutics for mitochondrial dysfunction in Alzheimer's disease.
Tuesday, April 27, 2010 | 9:00 AM - 5:00 PM
Organizers: Chad E. Beyer (University of Colorado School of Medicine), Mark R. Bowlby (Merck Research Laboratories), Ildiko Antal (Bristol-Myers Squibb), Beth Winkelstein (University of Pennsylvania), Jennifer Henry (The New York Academy of Sciences)
This symposium addresses clinical applications and new pain mechanisms for the treatment of chronic pain syndromes, and provides an update on the progress and barriers to developing effective preclinical models of pain, in particular fibromyalgia.
Friday, April 23, 2010 | 8:00 AM - 5:15 PM
Organizers: Paul Coplan (Purdue Pharma), Baruch Fischhoff (Carnegie Mellon University), Theresa Mullin (FDA), and Alice Till (PhRMA)
This conference will focus on a formalized, systematic approach for assessing drug risks and benefits in the context of regulatory decisions about which drugs should come to market. Discussion will include ways to improve the transparency and communication of FDA decisions to the general public.
|
-
Annals
Edited by Elliott Vichinsky (Children's Hospital and Research Center, Oakland, California) and Ellis Neufeld (Harvard Medical School, Children's Hospital, Boston, Massachusetts)
Proceedings of the “Ninth Cooley's Anemia Symposium,” held at the New York Academy of Sciences.
eBriefing
Organizers: Doris Bucher (New York Medical College) and Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium revisited the 2009 outbreak and examined strategies against future outbreaks.
eBriefing
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation) and Sonya Dougal (The New York Academy of Sciences)
Damage to energy-producing organelles may lead to a cascade of events resulting in Alzheimer's disease. Insights into this process and the possibility of new drug targets were the topic of an Academy symposium.
eBriefing
Organizers: Ildiko Antal (Bristol-Myers Squibb), Chad E. Beyer (University of Colorado School of Medicine), Mark R. Bowlby (Merck Research Laboratories), Beth Winkelstein (University of Pennsylvania), and Jennifer Henry (The New York Academy of Sciences)
This symposium addressed clinical applications and new pain mechanisms for the treatment of chronic pain syndromes, and provided an update on the progress and barriers to developing effective preclinical models of pain, in particular fibromyalgia.
eBriefing
Speakers: William R. Jacobs, Jr. (Albert Einstein College of Medicine), Christopher Sassetti (University of Massachusetts Medical School), Dirk Schnappinger (Weill Cornell Medical College), Helena Boshoff (NIH), and Carl Nathan (Weill Cornell Medical College)
Organizers: Takushi Kaneko (TB Alliance) and Jennifer Henry (New York Academy of Sciences)
TB kills nearly 2 million people yearly, and now shows drug resistance. This symposium highlighted how the genetic information of the pathogen and genetic tools are used in the quest for new TB drugs.
Webinar Archive
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
Webinar Archive
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
Webinar Archive
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.
|
|
|